Session Details
[F1]Flash Talks I
Mon. Aug 24, 2026 4:30 PM - 5:00 PM JST
Mon. Aug 24, 2026 7:30 AM - 8:00 AM UTC
Mon. Aug 24, 2026 7:30 AM - 8:00 AM UTC
Noh Theater (1F)
[F1-01]Electroplated Ni targets for 61Cu/64Cu production in clinical cyclotrons
*Jose Daniel Campos Mendez1,2, Sounalet Thomas1, Erick Mora Ramirez2, Ferid Haddad1 (1. SUBATECH, Nantes University (France), 2. CICANUM, Universidad de Costa Rica (Costa Rica))
[F1-02]Approaches to improve actinide targets fabrication method for high-intensity beam experiments at the SHE Factory
*Nikolay Aksenov1, Elizaveta Pishchalnikova1, Boris Zhuikov2 (1. Flerov Laboratory of Nuclear Reactions, Joint Institute for Nuclear Research (Russia), 2. Institute for Nuclear Research, Russian Academy of Sciences (Russia))
[F1-03]High Apparent Molar Activity 64Cu Production, Purification, and Radiolabeling Using ARTMS’s Ni-64 Solid Targets and Purification Method
*Daniel Childs1, Esra Altinok1, Sogol Borjian1, Josh Cruz1, Michael Kovacs2, Marc Lacroix1, Josh Mason1, Behrad Saeedi Saghez1, Mojmir Suchy2, Linh Tran1 (1. Telix ARTMS Inc. (Canada), 2. Lawson Research Institute (Canada))
[F1-04]PRODUCTION OF CO-55 THROUGH AUTOMATED ELECTROPLATING AND PURIFICATION TECHNIQUES
*Mario Malinconico1, Mirea Ruscillo1, Edward Robins2, Chady Barkil2, Courtney Hollis2 (1. COMECER S.p.A. – R&D Department, Via Maestri del Lavoro, 90, 48014 Castel Bolognese, RA, Italy (Italy), 2. Molecular Imaging & Therapy Research Unit (MITRU), South Australian Health and Medical Research Institute (SAHMRI), North Terrace, Adelaide, SA 5000, Australia; (Australia))
[F1-05][89Zr]ZrCl4 Production and Purification Using ARTMS’s 89Y Solid Targets and Purification Methods to Prepare Various Formulations along with Associate Radiolabeling and Quality Control Testing
Behrad Saeedi Saghez1, Mojmir Suchy2, Dan Childs1, *Marc Lacroix1, Linh Nguyen Thao Tran1, Josh Mason1, Josh Cruz1, Esra Altinok1, Michael Kovacs2, Sogol Borjian1 (1. Telix ARTMS inc. (Canada), 2. Lawson Research Institute (Canada))
[F1-06]Development and Evaluation of a High-Performance Solid Target System using Gold Substrate for 68Ga Production
*Mahesh Tiwari1,2, Mohd Faheem1, Manish Dixit1 (1. Department of Nuclear Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP – 226014 (India), 2. Redcare Research Private Limited, Lucknow, UP – 226010 (India))
[F1-07]Radionuclides provided by the Cyclone 18/9® cyclotron in Leipzig
*Karsten Franke1,2 (1. Institute of Resource Ecology, Helmholtz-Zentrum Dresden-Rossendorf(HZDR) (Germany), 2. Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf(HZDR) (Germany))
[F1-08]Development of a Large-Scale Production System for Astatine-211 for Targeted Alpha-Particle Therapy
*Hiroshi Arata1,2, Takashi Kurihara1,2, Hideyuki Arai1,2, Nozomi Sato2, Akihiro Nambu2, Yousuke Kanayama2, Tomohiro Tomitsuka2, Sayantani Mitra2, Tamaki Watanabe2, Hiromitsu Haba2 (1. Metal Technology Co. Ltd. (Japan), 2. Nishina Center for Accelerator-Based Science, RIKEN (Japan))
[F1-09]Production of 211At with 7Li ion beams and development of the 211Rn–211At generator system
*Ichiro Nishinaka1 (1. Takasaki Institute for Advanced Quantum Science, National Institutes for Quantum Science and Technology (Japan))
[F1-10]Detection of 225/226Ra Impurities in 225Ac Isotope Products using Extraction Chromatography and Microprecipitation Techniques
*Madeleine Anne Eddy1, Daniel McAlister1 (1. Eichrom Technologies (USA))
[F1-11]Evaluation of xSPECT-CG and xSPECT-EM Reconstruction Algorithms for 225Ac-DOTATATE Image-Based Dosimetry
*Muath Almaslamani1, Jingyu Yang1, Ilhan Lim1, Sang-Keun Woo1 (1. Korea Institute of Radiological and Medical Sciences (Korea))
[F1-12]Production of Scandium-47 Using a Multi-State Fusion Neutron Source
Maddie Woodward1, Robert Annewandter1, Han Ying-Liu1, Owen Thomas1, *Tom Haywood1 (1. Astral Systems (UK))
[F1-13]Advancing Targetry and Target Chemistry utilizing Fusion source based on Multi-State Fusion
*Han-Ying Liu1, Hugo Dominguez1, Owen Thomas1, Robert Annewandter1, Alex O'Farell1, Shuvay Singh1, Maddie Woodward1, Tom Haywood1, Tom Wallace-Smith1, Talmon Firestone1, Mahmoud Bakr1 (1. Astral Systems (UK))
[F1-14]Production of high radioisotopic purity 73Se for in vivo application at a 30 MeV cyclotron
*Swen Humpert1, Davit Gabadadze1, Lucas Mues1, Bernd Neumaier1,2 (1. Forschungszentrum Jülich GmbH, Institute of Neurosciences and Medicine, Nuclear Chemistry (INM-5), Wilhelm-Johnen-Str., 52428 Jülich, Germany (Germany), 2. Institute of Radiochemistry and Experimental Molecular Imaging, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany (Germany))
[F1-15]Recent advances at the ARRONAX facility
*Etienne NIGRON1 (1. GIP ARRONAX (France))
[F1-16]The Cyrcé facility in Strasbourg
*Michel Pellicioli1 (1. CNRS IPHC UMR7178 (France))
[F1-17]UAB Cyclotron Facility: When Radiometals drive changes.
*Jean-Pierre K. Appiah1 (1. University of Alabama at Birmingham (USA))
[F1-18]Production and Purification of 139Ce via the 139La(p,n)139Ce Reaction Using a La2O3 Pellet Target
*Terumi Yokoyama1, Hiroki Aoto1, Eishun Kawagishi1, Atsushi Toyoshima2, Masashi Murakami2, Yukiyoshi Kon2, Hiroyuki Kazama1, Masashi Kaneko1, Yika Hui1, Yoshitaka Kasamatsu1 (1. Graduate School of Science, The University of Osaka (Japan), 2. Institute for Radiation Sciences, The University of Osaka (Japan))
[F1-19]Ultrafast TcO4- Separation for Target and Post-Irradiation Processing Using a Functional Amyloid Fibril Hybrid Membrane
*Fan Zhang1, Kazuaki Tsukada1, Hiroshi Watabe1 (1. Tohoku University (Japan))
[F1-20]Spectroscopic Online Monitoring For Target Dissolution and Separation via Solvent Extraction
*Justin Cooper1, Mathew Snow1 (1. Idaho National Laboratory (USA))
[F1-21]Investigation of Daughter Radionuclide Release from the 103Pd/103mRh In Vivo Generator for Auger Electron Therapy
*Aicha Nour Laouameria1,2, Cathryn H. S. Driver3,4, Monika Buys4, Elena Sergeevna Kurakina5, Mátyás Hunyadi2, Jan Rijn Zeevaart3,4, Zoltán Szűcs2 (1. Doctoral School of Chemistry, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary (Hungary), 2. HUN-REN Institute for Nuclear Research, Bem tér 18/c, 4026 Debrecen, Hungary (Hungary), 3. NuMeRI, Nuclear Medicine Research Infrastructure NPC, Steve Biko Academic Hospital, Pretoria 0084, South Africa (South Africa), 4. Applied Radiation, South African Nuclear Energy Corporation (Necsa), Pelindaba 0240, South Africa (South Africa), 5. Dzhelepov Laboratory of Nuclear Problems, Joint Institute for Nuclear Research, Dubna 141980, Russia (Russia))
[F1-22]Development of 45Ti-Labeled PSMA-Targeting Tracers and Radiochemical Evaluation of Desferrioxamine-Derived Chelators
*Renjuan Liu1, Chubina Pathma Kumarananthan2, Tom Christian Holm Adamsen2, Ren Iwata1, Shozo Furumoto1 (1. Tohoku University (Japan), 2. Haukeland University Hospital (Norway))